(LXS) LANXESS Aktiengesellschaft - Ratings and Ratios

LANXESS Aktiengesellschaft is a global specialty chemicals company that develops, manufactures, and markets a wide range of chemical products, including intermediates, additives, and consumer protection products. The companys diverse product portfolio serves various industries, such as agrochemicals, pharmaceuticals, automotive, construction, and electronics. With a presence in multiple markets worldwide, LANXESS has established itself as a leading player in the specialty chemicals sector.

The companys business is organized into three main segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The Consumer Protection segment provides products that cater to the growing demand for hygiene and preservation solutions, as well as liquid purification technologies. The Specialty Additives segment offers a range of additives and lubricants used in various applications, including rubber, plastics, and construction materials. Meanwhile, the Advanced Intermediates segment supplies basic and fine chemicals, organometallics, and inorganic pigments to industries such as agrochemicals, automotive, and semiconductors.

With a rich history dating back to 1863, LANXESS has evolved into a global company with its headquarters in Cologne, Germany. The companys commitment to innovation and customer satisfaction has enabled it to maintain a strong presence in the market. For more information, you can visit the companys website at https://lanxess.com.

Analyzing the and of LANXESS, we can observe that the stock has been trading around its 20-day simple moving average (SMA20) of 26.65, with the last price being 26.54. The stocks 52-week high and low are 32.83 and 21.46, respectively, indicating a significant price range. The average true range (ATR) is 1.02, representing a 3.84% volatility. The companys market capitalization stands at 2334.80M EUR, with a forward price-to-earnings ratio of 14.58. Given the current technical and fundamental indicators, a potential forecast could be that the stock may experience a moderate increase in the short term, potentially reaching 28-30 EUR, driven by a rebound in the specialty chemicals sector and the companys efforts to improve its profitability. However, the negative return on equity (RoE) of -3.04% may pose a challenge to the stocks performance. A more detailed analysis of the companys financials and industry trends would be necessary to confirm this forecast.